Acquisition Opportunity EXTEDO recently announced Bertelsmann Investments’ acquisition in Feb 2024, signaling a potential avenue for cross sell or expanded regulatory information management services to a larger investment-backed growth sponsor with global reach.

Regulatory Platform Depth The company offers end to end RIM solutions including master data, content, quality, submissions (eCTD and variants), and pharmacovigilance, presenting multiple up sell opportunities to existing clients and potential for bundled regulatory lifecycle offerings.

Global Footprint Serving around 35 regulatory authorities and 1000 customers across 65 countries, EXTEDO’s international footprint creates multi market expansion opportunities for new customers in biotech, medical devices, crop science and consumer health segments.

Tech Stack Leverage With capabilities spanning TYPO3, Oracle, Jira, and cloud and collaboration tools, there is potential to offer modernization, integration, or migration services to clients seeking enhanced regulatory workflows and digital submissions.

Growth Readiness Revenue range and growth signals, combined with recent investments and partnerships, indicate readiness for scale by adding strategic partnerships, add on modules such as DMS expansion, and targeted selling to mid to large CROs and pharma with complex regulatory programs.